EconPapers    
Economics at your fingertips  
 

Intervention stigma: How medication-assisted treatment marginalizes patients and providers

Erin Fanning Madden

Social Science & Medicine, 2019, vol. 232, issue C, 324-331

Abstract: Methadone and buprenorphine are drugs used to treat opioid use disorders, and are labeled the “gold standard” of treatment by the National Institutes of Health. Yet associating with these forms of medication-assisted treatment (MAT) subjects individuals to stigma from healthcare personnel both within and outside addiction treatment communities. This study uses the case of MAT to propose a new category of stigma: “intervention stigma.” Unlike “condition stigmas” that mark individuals due to diagnosis, intervention stigma marks patients and health professionals due to involvement with a medical treatment or other form of intervention. In-depth interviews with 47 addiction treatment professionals explore how individuals working in MAT experience discrimination and prejudice from other healthcare professionals, especially abstinent treatment professionals who disagree with the use of medications to treat opioid use disorders. This discrimination and prejudice stems at times from stigma toward addiction diagnoses, and at other times toward unique features of MAT itself. The experiences of addiction treatment professionals illustrate how medical interventions can mark patients and professionals in ways that affect patient care, and thus must be added to the scope of destigmatization efforts operating in the health sector.

Keywords: United States; Stigma; Medical intervention; Medication-assisted treatment; Opioids; Addiction; Treatment; Behavioral health; Health professionals (search for similar items in EconPapers)
Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (5)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0277953619302916
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:socmed:v:232:y:2019:i:c:p:324-331

Ordering information: This journal article can be ordered from
http://www.elsevier.com/wps/find/supportfaq.cws_home/regional
http://www.elsevier. ... _01_ooc_1&version=01

DOI: 10.1016/j.socscimed.2019.05.027

Access Statistics for this article

Social Science & Medicine is currently edited by Ichiro (I.) Kawachi and S.V. (S.V.) Subramanian

More articles in Social Science & Medicine from Elsevier
Bibliographic data for series maintained by Catherine Liu ().

 
Page updated 2025-03-19
Handle: RePEc:eee:socmed:v:232:y:2019:i:c:p:324-331